Ghielmini, M.; Rufibach, K.; Salles, G.; Leoncini-Franscini, L.; Léger-Falandry, C.; Cogliatti, S.; Fey, M.; Martinelli, G.; Stahel, R.; Lohri, A.; Ketterer, N.; Wernli, M.; Cerny, T.; Hsu Schmitz, S.-F. (2005). Single agent rituximab in patients with follicular or mantle cell lymphoma: clinical and biological factors that are predictive of response and event-free survival as well as the effect of rituximab on the immune system: a study of the Swiss Group for Clinical Cancer Research (SAKK). Annals of oncology, 16(10), pp. 1675-1682. Oxford University Press 10.1093/annonc/mdi320
|
Text
mdi320.pdf - Published Version Available under License Publisher holds Copyright. Download (194kB) | Preview |
Item Type: |
Journal Article (Original Article) |
|---|---|
Division/Institute: |
04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Medical Oncology |
ISSN: |
0923-7534 |
Publisher: |
Oxford University Press |
Language: |
English |
Submitter: |
Markus Müller |
Date Deposited: |
01 Oct 2018 16:02 |
Last Modified: |
23 Oct 2019 18:20 |
Publisher DOI: |
10.1093/annonc/mdi320 |
BORIS DOI: |
10.7892/boris.115563 |
URI: |
https://boris.unibe.ch/id/eprint/115563 |
Actions (login required)
 |
Edit item |